Pila Pharma AB (PILA) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.644x

Based on the latest financial reports, Pila Pharma AB (PILA) has a cash flow conversion efficiency ratio of -1.644x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.91 Million ≈ $-205.06K USD) by net assets (Skr1.16 Million ≈ $124.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PILA defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Pila Pharma AB - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Pila Pharma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pila Pharma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pila Pharma AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Home Pottery Public Company Limited BK:HPT	0.010x
Hays plc LSE:HAS	0.122x
Sipa Resources Ltd AU:SRI	-1.068x
Hemostemix Inc V:HEM	0.839x
FOS Capital Ltd AU:FOS	0.031x
Strategic Energy Resources Ltd AU:SER	-0.023x
Sahakol Equipment Public Company Limited BK:SQ	0.164x
MEDAPP S.A. ZY -10 F:WQ1	0.076x

Annual Cash Flow Conversion Efficiency for Pila Pharma AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Pila Pharma AB from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Pila Pharma AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr14.78 Million ≈ $1.59 Million	Skr-9.19 Million ≈ $-988.56K	-0.621x	+58.21%
2024-12-31	Skr5.26 Million ≈ $566.17K	Skr-7.82 Million ≈ $-841.88K	-1.487x	-104.07%
2023-12-31	Skr6.66 Million ≈ $716.87K	Skr-4.85 Million ≈ $-522.37K	-0.729x	+23.61%
2022-12-31	Skr9.53 Million ≈ $1.03 Million	Skr-9.09 Million ≈ $-978.34K	-0.954x	-208.63%
2021-12-31	Skr30.30 Million ≈ $3.26 Million	Skr-9.36 Million ≈ $-1.01 Million	-0.309x	+47.16%
2020-12-31	Skr3.42 Million ≈ $368.07K	Skr-2.00 Million ≈ $-215.30K	-0.585x	+13.15%
2019-12-31	Skr7.46 Million ≈ $802.59K	Skr-5.02 Million ≈ $-540.56K	-0.674x	+4.17%
2018-12-31	Skr6.49 Million ≈ $698.79K	Skr-4.56 Million ≈ $-491.12K	-0.703x	--

About Pila Pharma AB

ST:PILA Sweden Biotechnology

Market Cap

$6.81 Million

Skr63.27 Million SEK

Market Cap Rank

#27929 Global

#619 in Sweden

Share Price

Skr1.39

Change (1 day)

+1.84%

52-Week Range

Skr1.10 - Skr3.79

All Time High

Skr12.40